26 Jul Instil Bio
Zachary Robert, M.D., Ph.D., Chief Medical Officer Oct. 12 | 5:45pm | UBC Ballroom Dallas, TX (NASDAQ: TIL) In-person Presentation Instil Bio is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer (solid tumors). Using an optimized and scalable...